USP Drug Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
 Blood Products and Modifiers
 Cardiovascular Agents
 Central Nervous System Agents
   Amyotrophic Lateral Sclerosis (ALS) Agents
   Attention Deficit Hyperactivity Disorder Agents, Amphetamines
   Attention Deficit Hyperactivity Disorder Agents, Non-amphetamines
   Fibromyalgia Agents
   Multiple Sclerosis Agents
     Dimethyl Fumarate
     Diroximel Fumarate
     Monomethyl Fumarate
     Dalfampridine
     Teriflunomide
     Interferon Beta-1a [DG:DG01751]
     Interferon Beta-1b [DG:DG01751]
     Peginterferon Beta-1a
       D10483  Peginterferon beta-1a (USAN/INN)
     Fingolimod [DG:DG00741]
     Ozanimod [DG:DG02827]
     Siponimod [DG:DG03018]
     Alemtuzumab
     Cladribine
     Glatiramer
     Mitoxantrone [DG:DG00701]
     Natalizumab
     Ocrelizumab
     Ponesimod
     Ublituximab
   Central Nervous System, Other
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: January 9, 2024
According to the USP Drug Classification 2024

» Japanese version